Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata

Cheng Zhou, Xiumin Yang, Bin Yang, Guofu Yan, Xiuqin Dong, Yangfeng Ding and 14 more

Rank
14 of 1,810
Percentile
top 0.8%
Where
Journal of the American Academy of Dermatology, 2023
Citations
53

From the 2023 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.